Brighton Jones’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Sell
2,091
-825
-28% -$427K 0.02% 481
2026
Q2
$1.58M Sell
2,916
-204
-7% -$115K 0.03% 367
2026
Q1
$1.85M Buy
+3,120
New +$1.55M 0.04% 287
2025
Q4
– Sell
-1,502
Closed -$630K – 904
2025
Q3
$630K Buy
1,502
+362
+32% +$122K 0.02% 548
2025
Q2
$327K Buy
+1,140
New +$341K 0.01% 687

Other funds holding UTHR

Brighton Jones's UTHR Position: Q3 2026 in Review

Brighton Jones reduced its United Therapeutics (UTHR) stake by 28% in Q3 2026, selling an estimated $427K and leaving 2,091 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #481.

Brighton Jones first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.85M in Q1 2026. 686 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Brighton Jones held 2,091 shares of United Therapeutics worth $1.13M as of Q3 2026.
  • Brighton Jones sold 825 United Therapeutics shares in Q3 2026, an estimated $427K.
  • United Therapeutics made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #481 holding.
  • Brighton Jones first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Brighton Jones's United Therapeutics position peaked at $1.85M in Q1 2026.
  • 686 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.